CD8A and neoplasm: And in vivo depletion of CD8 + T cells by antibody treatment confirmed that MSA-2 can induced the robust priming, trafficking to and tumor infiltration of CD8 + T cells, underscoring the immune regulation of MSA-2 in the syngeneic ccRCC models.